AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved a new indication in the US, expanding the use of Faslodex® (fulvestrant) to include use in combination with...
FDA approves first coagulation factor-albumin fusion protein to treat patients with hemophilia B
3/07/2016
The U.S. Food and Drug Administration has approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B.
Biofrontera AG, the specialist for suninduced skin cancer, has announced the full results of its Phase III clinical trial evaluating BF-200 ALA for the treatment of basal cell carcinoma (BCC) that...
AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved a new indication in the US, expanding the use of Faslodex® (fulvestrant) to include use in combination with...
FDA approves first coagulation factor-albumin fusion protein to treat patients with hemophilia B
3/07/2016
The U.S. Food and Drug Administration has approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B.
New IOM report underscores diversity of ovarian cancer subtypes, highlights research priorities
3/07/2016
Ovarian cancer, one of the deadliest malignancies, is actually a constellation of different cancers that may originate in other organs and should not be treated as a single disease, concludes a new...
New IOM report underscores diversity of ovarian cancer subtypes, highlights research priorities
3/07/2016
Ovarian cancer, one of the deadliest malignancies, is actually a constellation of different cancers that may originate in other organs and should not be treated as a single disease, concludes a new...
UK diagnoses children's kidney cancer at a later stage than Germany
3/07/2016
THE UK diagnoses Wilms' tumours - the most common children's kidney cancer - when they are larger and more advanced compared with those diagnosed in Germany, according to a Cancer Research...
New vulnerability revealed in blood cancer development
3/07/2016
Walter and Eliza Hall Institute researchers have uncovered a protein that is key to the development of blood cancers caused by a common genetic error.
Fungal pathogen sheds gene silencing machinery and becomes more dangerous
3/07/2016
For more than a decade, a rare but potentially deadly fungus called Cryptococcus deuterogatti has taken up residence in the Pacific Northwest and Vancouver Island.